University of Limerick Institutional Repository

Adherence to antiretrovirals among US women during and after pregnancy

DSpace Repository

Show simple item record

dc.contributor.author Bardeguez, Arlene D.
dc.contributor.author Lindsey, Jane C.
dc.contributor.author Shannon, Maureen
dc.contributor.author Tuomala, Ruth E.
dc.contributor.author Cohn, Susan E.
dc.contributor.author Smith, Elizabeth
dc.contributor.author Stek, Alice
dc.contributor.author Buschur, Shelly
dc.contributor.author Cotter, Amanda
dc.contributor.author Bettica, Linda
dc.contributor.author Read, Jennifer S.
dc.date.accessioned 2016-02-18T14:52:33Z
dc.date.available 2016-02-18T14:52:33Z
dc.date.issued 2009
dc.identifier.uri http://hdl.handle.net/10344/4897
dc.description peer-reviewed en_US
dc.description.abstract Background—Antiretrovirals (ARVs) are recommended for maternal health and to reduce HIV-1 mother-to-child transmission, but suboptimal adherence can counteract its benefits. Objectives—To describe antepartum and postpartum adherence to ARV regimens and factors associated with adherence. Methods—We assessed adherence rates among subjects enrolled in Pediatric AIDS Clinical Trials Group Protocol 1025 from August 2002 to July 2005 on tablet formulations with at least one self-report adherence assessment. Perfectly adherent subjects reported no missed doses 4 days before their study visit. Generalized estimating equations were used to compare antepartum with postpartum adherence rates and to identify factors associated with perfect adherence. Results—Of 519 eligible subjects, 334/445 (75%) reported perfect adherence during pregnancy. This rate significantly decreased 6, 24, and 48 weeks postpartum [185/284 (65%), 76/118 (64%), and 42/64 (66%), respectively (P < 0.01)]. Pregnant subjects with perfect adherence had lower viral loads. The odds of perfect adherence were significantly higher for women who initiated ARVs during pregnancy (P < 0.01), did not have AIDS (P = 0.02), never missed prenatal vitamins (P < 0.01), never used marijuana (P = 0.05), or felt happy all or most of the time (P < 0.01). Conclusions—Perfect adherence to ARVs was better antepartum, but overall rates were low. Interventions to improve adherence during pregnancy are needed. en_US
dc.language.iso eng en_US
dc.publisher Lippincott Williams & Wilkins en_US
dc.relation.ispartofseries Journal of Acquired Immune Deficiency Syndromes;48 (4), pp. 408-417
dc.relation.uri http://dx.doi.org/10.1097/QAI.0b013e31817bbe80
dc.rights This is the author version of " Adherence to Antiretrovirals Among US Women During and After Pregnancy" the final published version is available at http://dx.doi.org/10.1097/QAI.0b013e31817bbe80 en_US
dc.subject pregnancy en_US
dc.subject adherence en_US
dc.subject HIV-1 infection en_US
dc.subject substance use en_US
dc.subject depression en_US
dc.subject viral suppression en_US
dc.title Adherence to antiretrovirals among US women during and after pregnancy en_US
dc.type info:eu-repo/semantics/article en_US
dc.type.supercollection all_ul_research en_US
dc.type.supercollection ul_published_reviewed en_US
dc.rights.accessrights info:eu-repo/semantics/openAccess en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search ULIR


Browse

My Account

Statistics